The Patent Finder

Extracellular Matrix from Pluripotent Cells

Sanbio, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2008/013297, filed Dec 3, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,471,102Extracellular Matrix from Pluripotent Cells
In force
 · High confidence
Sanbio, Inc.In force
High confidence
US 10,653,724Extracellular Matrix from Pluripotent Cells
In force
 · High confidence
Sanbio, Inc.In force
High confidence
US 10,702,554Extracellular Matrix from Pluripotent Cells
In force
 · High confidence
Sanbio, Inc.In force
High confidence
Application 14/465,344Extracellular Matrix from Pluripotent Cells
Abandoned
Abandoned Jul 26, 2018
SanBio, Inc.AbandonedAbandoned Jul 26, 2018
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Sanbio, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited